Implantable flap prosthesis

DE502018015306D1Active Publication Date: 2024-11-28UNIVERSITAETSKLINIKUM HAMBURG EPPENDORF
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE502018015306
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2017-09-13
Filing Date
2018-09-06
Publication Date
2024-11-28
Estimated Expiration
2038-09-06

AI Technical Summary

Technical Problem

Current interventional procedures for treating mitral and tricuspid valve insufficiency are limited by anatomical and morphological variations, failing to effectively prevent blood backflow in all patients, particularly those with severe valve dilatation or complex anatomical conditions.

Method used

An implantable valve prosthesis featuring a tubular stent with a flexible tube that collapses under pressure differences, allowing for minimal resistance to physiological flow while effectively preventing backflow by anchoring in a vein and projecting into the atrium, independent of valve anatomy or morphology.

Benefits of technology

The valve prosthesis provides effective prevention of blood backflow into the lungs or vena cavae, reducing symptoms like dyspnea and edema without significant flow obstruction, suitable for patients unsuitable for surgical or traditional interventional therapies.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The invention relates to an implantable valve prosthesis, in particular for preventing blood backflow from an atrium into a vein opening into the atrium.

[0002] The mitral valve serves to prevent the backflow of blood from the left ventricle into the left atrium during systole. However, mitral valve regurgitation is highly prevalent. The main clinical symptom of severe mitral valve regurgitation is dyspnea, caused by blood backflow into the lungs. In addition to surgical mitral valve repair or replacement, interventional procedures are available. Mitral valve prostheses, for example, have been described in the prior art as replacements for the mitral valve (see, for example, US 5258023 A, US 7641686 B2, Vaquerizo et al. 2015, Percutaneous Transcatheter Mitral Valve Replacement: Patient-specific Three-dimensional Computer-based Heart Model and Prototyping, Rev. Esp.Cardiol. 68, 1165-1173, doi: 10.1016 / j.rec.2015.08.005; Jamieson et al. 2009, Mitroflow aortic pericardial bioprosthesis - clinical performance, Eur J Cardiothorac Surg 36, 818-824, doi: 10.1016 / j.ejcts.2009.05.020).

[0003] The tricuspid valve's function is to prevent the backflow of blood from the right ventricle into the right atrium during systole. Tricuspid valve regurgitation is a common clinical problem in patients with impaired right ventricular function. Apart from surgical tricuspid valve repair or replacement, no clinically established interventional procedures are currently available. The main clinical symptoms of severe tricuspid regurgitation are blood backflow in the liver and kidneys, ascites, and edema. Over time, this leads to liver and kidney dysfunction.

[0004] However, the known prostheses and procedures are not promising for all patients, as interventional procedures for repairing the mitral or tricuspid valve reach their limits due to various anatomical and valve morphological conditions, such as severe dilation of the mitral or tricuspid annulus or other anatomical conditions. WO 2014 / 165010 describes a tubular braided mesh scaffold for the production of heart valves with a shell that forms the valve leaflets.

[0005] The object of the present invention is therefore to provide an alternative to the previously available means for treating mitral valve or tricuspid valve insufficiency, which can be used in particular independently of the anatomy and morphology of the mitral and tricuspid valves.

[0006] The problem is solved by an implantable valve prosthesis, in particular for preventing blood backflow from an atrium into a vein flowing into the atrium, comprising a generally tubular stent, which may be branched or unbranched and has at least a first end section with a first end opening and a second end section with a second end opening, and a flexible tube, which may be branched or unbranched and has at least a first end section with a first end opening and a second end section with a second end opening that can be closed by collapsing the tube, which flexible tube is arranged at least in a partial region of the second end section of the stent on its outer peripheral surface such that the tube with its second end section and the second end opening projects beyond the second end opening of the stent, wherein the second end opening of the tube is open in the unpressurized state.

[0007] The valve prosthesis according to the invention can be implanted interventionally and is particularly well suited to prevent or minimize blood backflow from the left atrium through the pulmonary veins to the lungs or blood backflow from the right atrium into the vena cavae, and can thus be used in symptomatic therapy of mitral valve insufficiency or tricuspid valve insufficiency.

[0008] The valve prosthesis is designed in such a way that one end of it can be anchored interventionally in a pulmonary or vena cava, while the other end protrudes freely into the corresponding atrium. The valve prosthesis is designed in such a way that the valve is open in the neutral state, i.e. when the end of the tube protruding into the atrium is not subjected to external positive or internal negative pressure, while the valve is closed when the end of the tube collapses when there is external pressure or internal negative pressure. Exposure to external positive or internal negative pressure at the end of the tube can, for example, be the result of backflow of blood from the contracting left ventricle into the left atrium due to an inadequately sealing mitral valve or backflow of blood from the contracting right ventricle into the right atrium due to an inadequately sealing tricuspid valve.

[0009] Due to this valve design, there is no or only a slightly increased flow resistance during physiological flow from the pulmonary veins toward the left atrium or from the vena cava toward the right atrium. Compared to conventional heart valves, which are normally closed and only open upon overcoming resistance, the flow resistance of the valve according to the invention is almost negligible. In the event of unphysiological backflow from the atrium toward the veins flowing into the atrium, the resulting negative pressure inside the tube end extending into the atrium or positive pressure in the atrium causes the tube valve to collapse, thus preventing the valve from properly closing.Backflow into the lungs and the associated dyspnea, the main symptom of mitral regurgitation, or backflow into the vena cavae, resulting in blood backflow to the liver and kidneys, is thus prevented without the valve becoming a significant obstruction to normal blood flow. Thus, patients for whom surgical treatment is too risky and a conventional interventional procedure is not possible for anatomical reasons can be offered symptomatic treatment of mitral or tricuspid regurgitation. This is completely independent of the pathology and anatomical features of the mitral or tricuspid valve.

[0010] The expression "for preventing backflow of blood from an atrium into a vein leading into the atrium" in relation to the implantable valve prosthesis according to the invention refers to the suitability of the valve prosthesis for preventing backflow of blood from the left atrium into a pulmonary vein or from the right atrium into a vena cava.

[0011] The term "interventionally implantable" in relation to the valve prosthesis according to the invention means that the valve prosthesis can be implanted minimally invasively using a vascular catheter.

[0012] A "stent" is an implantable support or stiffening device used to open or keep open vessels or hollow organs. They are made of biocompatible material, such as metal or plastic. For example, they can be a generally tubular structure made of a metal and / or plastic fiber mesh or mesh.

[0013] A "generally tubular stent" is understood to be a stent with a generally tubular shape. For example, the stent can be designed as a generally hollow cylindrical tube, with a round or elliptical cross-section. A "branched stent" is understood to be a stent with at least one fork. For example, the stent can have a Y-shape, so that one tube splits into two tubes at a fork. Branched, for example, Y-shaped stents are already known in principle and are described, for example, in EP 0830109 B1.

[0014] When we speak here of a "stent opening", a "stent end opening" or an "open stent end", this obviously does not refer to an opening between wires of the wire mesh forming the stent wall or stent sheath, but to an opening located at the end of a stent section and surrounded by the stent wall.

[0015] A "flexible tube" is understood here to be a tube that is not rigid but slightly flexible. In particular, this term refers to a tube that is collapsible, i.e., that collapses or is compressed under pressure conditions such as those that occur under physiological conditions in the left atrium during systole, particularly at the end of the contraction phase or at the beginning and during the ejection phase of ventricular systole, so that the tube is essentially closed under these conditions. The term "physiological" here also includes conditions that can occur under pathological conditions, for example, in the case of mitral valve insufficiency or tricuspid valve insufficiency in the human or animal body.A "branched hose" is understood here to be a hose that divides or forks into separate hose-shaped sections, for example a Y-shaped hose.

[0016] The term "collapse" in relation to an end section of the flexible tube refers to the collapsing, invagination, invagination, or compression of the tube in that section, so that the tube wall is pulled or pushed toward the interior of the tube and regions of the inner wall of the tube abut against one another, reversibly closing the tube. The expression "closable" of the second end opening of the tube by its collapse means that the flow of blood from the second end opening of the tube to the first end opening of the tube can be substantially prevented by narrowing the tube cross-section in the tube section between the first and second end openings. This may include a cross-sectional narrowing of the second end opening itself, but this is not necessary, particularly in the embodiments described in more detail below, in which the end opening has a reinforcing element.

[0017] The expression "the second end of the hose is open in the depressurized state" means that under normal conditions, with no pressure difference between the inside and outside of the hose, the second end of the hose is not in a collapsed state, and the second end is open and permeable to fluid. A depressurized state, i.e., a state without a pressure difference between the inside and outside of the hose, is also referred to here as a "neutral state."

[0018] The term "mitral valve insufficiency" (also "mitral regurgitation", MI) refers to a heart valve defect in which the mitral valve (also bicuspid valve) of the heart, which is located between the left atrium and the left chamber (ventricle) of the heart and, when functional, prevents a systolic backflow of blood from the left chamber into the left atrium, is impaired in its function, i.e. is unable to close or is leaky, so that during the ejection phase of ventricular systole, there is a backflow of blood from the left ventricle into the left atrium.

[0019] The term "tricuspid valve insufficiency" (also "tricuspid insufficiency", TI) refers to a heart valve defect in which the tricuspid valve of the heart, which is located between the right atrium and the right chamber (ventricle) of the heart and, when functional, prevents a systolic backflow of blood from the right chamber into the right atrium, is impaired in its function, i.e. is unable to close or is leaky, so that during the ejection phase of ventricular systole, there is a backflow of blood from the right ventricle into the right atrium.

[0020] The term "pulmonary veins" or "pulmonary veins" refers to the venae pulmonales, blood vessels that carry oxygen-rich blood from the lungs to the left atrium of the heart. In humans, there are typically four pulmonary veins (inferior and superior right pulmonary veins, and inferior and superior left pulmonary veins), which drain separately into the left atrium.

[0021] The term "vena cava" refers to the venae cavae, i.e., blood vessels that transport venous blood from the body to the right atrium of the heart. Humans typically have two vena cavae: the superior vena cava and the inferior vena cava. The valve prosthesis according to the invention is designed such that the end of the tube extending beyond the stent collapses when implanted and is thereby closed when the pressure in the atrium increases during systole. Keeping the tube open during the extrasystolic phases of the cardiac cycle, particularly during the filling phase (diastole), can be achieved either by appropriately selecting the tube material and / or wall thickness and / or by suitable support elements. The tube has sufficient flexibility / elasticity to open due to the passive flow from the lungs into the atrium at the onset of diastole.When the pressure in the atrium increases at the beginning of systole, the valve is closed by collapsing the tube, closing the end opening.

[0022] The stent can be implanted using a method known in the art, for example, using a balloon catheter. The initially folded stent is then delivered to the desired location, such as a pulmonary vein orifice or vena cava in the associated atrium, using the catheter, where it is expanded and anchored. Alternatively, the valve can be made of a self-expanding material (e.g., a nickel-titanium alloy, nitinol), which expands to the desired size after the stent is released and comes into contact with the bloodstream. The principles of the self-expanding valve are known to those skilled in the art.

[0023] In a preferred embodiment of the valve prosthesis according to the invention, it comprises at least one wire- or band-shaped stabilizing element attached to the stent or formed integrally with the stent, wherein the stabilizing element projects beyond the second end opening of the stent and supports the part of the tube projecting beyond the second end opening of the stent from the inside such that the second end opening of the tube is open in the pressure-free state and cannot reach the second end opening of the stent when pressurized. In this embodiment, a wire- or band-shaped stabilizing element extends from the stent end or beyond the stent end towards the tube end and supports the tube from the inside so that collapse, e.g. the invagination of the protruding tube part into the interior of the stent, is prevented in the neutral state.Furthermore, the wire- or band-shaped stabilizing element also prevents the tube end from invaginating into the stent in the event of external overpressure or internal negative pressure, particularly during valve closure. This prevents the part of the tube extending beyond the second end opening of the stent from being pushed or sucked back into the interior of the stent. The stabilizing element preferably extends to the tube end.

[0024] Particularly preferably, at least two opposing wire- or band-shaped stabilizing elements are provided, supporting the tube from the inside. In this embodiment, collapse of the tube is essentially only possible by inward movement of the wall regions of the tube located between the stabilizing elements. This embodiment has been shown to function particularly reliably and prevent unintentional collapse of the tubular flap portion.

[0025] As described above, the at least one wire- or band-shaped stabilizing element also prevents invagination of the tube back into the stent, e.g. in negative pressure situations. Alternatively or additionally, it can also be provided that the tube widens in cross-section towards its second end opening and / or has an annular reinforcing element attached to the outside of the tube in its second end section. The internal cross-section of the annular reinforcing element preferably corresponds at least to the internal cross-section of the second end opening of the stent, so that penetration of the tube with its second end opening into the stent is not possible. By widening towards the second end opening, the flow resistance is further reduced due to the enlargement of the tube cross-section.The annular reinforcing element stiffens the tube in its second end section, for example in the region of its second end opening, and ensures that the tube cannot be retracted into the stent. In this embodiment, the length of the tube section between the second stent end and the annular reinforcing element is selected such that the tube can close completely in this section. The annular reinforcing element can be arranged both in embodiments with a cross-sectional widening of the tube towards the second end opening and in embodiments without such a cross-sectional widening. In the case of an embodiment with a cross-sectional widening, the inner cross-section of the annular reinforcing element is larger than the inner cross-section of the second end opening of the stent.

[0026] The implantable valve prosthesis according to the invention is preferably designed such that, when the valve prosthesis is fully closed, a coaptation length L of at least 1 cm, preferably at least 1.2 cm, 1.3 cm, or 1.5 cm, results. The coaptation length is understood to be the length of the tube region in the longitudinal direction of the valve prosthesis, i.e., in the flow direction of the blood flowing through the valve prosthesis, over which the opposing tube sections maximally overlap when the valve prosthesis is closed. The desired coaptation length can be adapted, for example, by selecting a tube length suitable for the respective valve design.

[0027] In one embodiment of the invention, which is particularly well-suited for preventing blood backflow from the right atrium into a vena cava, two implantable valve prostheses, as described above, are connected to one another to form a valve prosthesis. In this embodiment, the implantable valve prosthesis according to the invention comprises a first and a second implantable valve prosthesis, as described above, wherein the first and second implantable valve prostheses are arranged opposite one another such that they are directed towards one another with their second tube end openings, the first and second implantable valve prostheses are spaced apart from one another with their second tube end openings, the first and second implantable valve prostheses each have a wire- or band-shaped stabilizing element which is fastened to the stent or formed integrally with the stent and which extends beyond the tube end openings of the first and second implantable valve prostheses, and the first and second implantable valve prostheses are connected to one another by the at least one wire- or band-shaped stabilizing element.

[0028] In this embodiment, two implantable valve prostheses are coupled to one another via the at least one wire- or band-shaped stabilizing element such that their second tube end openings are directed towards one another. The local stabilization of the valve prosthesis is increased in this embodiment. By spacing the tube end openings apart from one another, blood can flow between the second tube end openings into the atrium when the valve is open, i.e. during diastole. This embodiment of the implantable valve prosthesis can be implanted with the first end section of the first valve prosthesis in the superior vena cava and with the first end section of the second valve prosthesis in the inferior vena cava. The valve prosthesis has sufficient flexibility to adapt to various anatomical conditions.The tube lengths and their spacing can be adjusted to ensure reliable valve closure during systole. This embodiment can also include, for example, two wire- or band-shaped stabilizing elements, which can be arranged opposite each other or simply offset from each other in the circumferential direction.

[0029] In a particularly preferred embodiment of the implantable valve prosthesis according to the invention, the stent and the tube are unbranched and generally hollow-cylindrical. This embodiment is particularly simple to manufacture. The stent is generally hollow-cylindrical and can be inserted and anchored with its first open end, for example, into a pulmonary or vena cava. The tube, which is also generally hollow-cylindrical, can be applied to the section with the second open end. The second end of the tube, which in turn extends beyond the second end of the stent and into the atrium, can be applied.

[0030] In an alternative embodiment of the implantable valve prosthesis according to the invention, the stent and / or the tube are branched and generally Y-shaped. In one embodiment, the stent and the tube are Y-shaped. This embodiment can, for example, be arranged with two of its stent ends in the atrial orifices of the upper and lower left pulmonary veins, the upper and lower right pulmonary veins, or the superior and inferior vena cava, while the third stent end comprises the protruding tube end. In this way, two pulmonary veins or the vena cavae can be equipped with only one valve prosthesis. The cross-section of the stent section carrying the protruding tube end can be suitably enlarged together with the corresponding tube section to avoid flow restriction of the blood flowing through it.In another embodiment, only the tube is Y-shaped, while two tubular stents are inserted into two of the tube ends.

[0031] The tube may be made of a suitable biocompatible material, such as a plastic material, or of body tissue, preferably human or animal body tissue. Suitable tube materials are known to those skilled in the art.

[0032] The stent is made of a suitable biocompatible material, such as a suitable metal, e.g., titanium steel or nitinol, or plastic, e.g., polytetrafluoroethylene (PTFE) or polyetheretherketone (PEEK). Suitable stent materials are known to those skilled in the art.

[0033] The tube can be arranged over the entire surface of the stent, i.e. the stent can be covered by the tube over its entire outer circumferential surface, so that the tube is also present in the area where the stent is anchored in a vein. However, the stent can also be kept free of the tube in the areas intended for its anchoring in a vein, so that the implanted stent is in direct contact with the inner wall of a vein. The latter is advantageous in order to achieve the smallest possible reduction in the internal cross-section of the vessel and thus the smallest possible flow obstruction. The tube can be attached to the stent in a suitable manner, for example by sewing or gluing.

[0034] The implantable valve prosthesis according to the invention can have one or more fastening elements, e.g., made of wire, by means of which the valve prosthesis can be additionally anchored in the body, for example, with surgical suture material. For example, a wire-shaped fastening element can be passed through an implantation vein (e.g., subclavian vein) and secured with surgical suture material. In this way, the implantable valve prosthesis can be secured extravascularly, for example.

[0035] The invention is explained in more detail below with reference to the attached figures and an embodiment purely for illustrative purposes. Figure 1 . Two embodiments (A, B) of the valve prosthesis according to the invention in lateral views (top) and sectional views (bottom), in which the stent is completely (A) or only partially (B) covered by the tube. Figure 2. Simplified spatial views of the Figures 1A and 1B illustrated embodiments of the valve prosthesis according to the invention. Figure 3A-C . Views of further embodiments of the valve prosthesis according to the invention. Figure 4 Highly schematic representation of a left atrium with preferred embodiments of the valve prosthesis according to the invention inserted into the orifices of the pulmonary veins. Figures 5, 6 . Two further embodiments (A, B) of the valve prosthesis according to the invention in lateral views (top) and sectional views (bottom). Figure 7 . Views of two embodiments (A, B) of the valve prosthesis according to the invention, which is particularly suitable for implantation in the vena cavae. Figure 8 . Spatial views of the Figure 7 illustrated embodiments of the valve prosthesis according to the invention. Figure 9. Simplified sectional view of a human heart with an embodiment of the valve prosthesis according to the invention implanted in the vena cavae according to the Figures 7 and 8 . Figure 10 . Sectional view of an embodiment of a valve prosthesis according to the invention in the closed state. Figure 11 Echocardiography of a pig heart with a left atrial valve prosthesis implanted according to the invention. LA = left atrium, LAK = left atrial valve prosthesis.

[0036] Figure 1 shows two preferred embodiments of a valve prosthesis 1 according to the invention. The upper part of the figures shows a side view, the lower part a sectional view. The sectional view shows a section that is not at the level of the opposite (see also Fig. 2 ) wire or band-shaped stabilizing elements 12. The Figure 1A, B are generally hollow-cylindrical in shape. A generally hollow-cylindrical stent 2, which may be formed from a titanium steel mesh, has a first end section 4 with a first end opening 6 and a second end section 5 with a second end opening 7 opposite the first end opening 6. A flexible tube 3, which is also hollow-cylindrical and may be a fabric tube, and has a first end section 8 with a first end opening 10 and a second end section 9 with a second end opening 11, is arranged on the outer circumferential surface of the stent 2. The tube 3 is in the Fig. 1A illustrated embodiment is completely pulled over the stent 2 with its first end section 8 and ends with the first end opening 6 of the stent 2. In the Fig. 1BIn the embodiment shown, at least a part of the first end section 4 of the stent 2 is left free, ie, not covered by the tube 3. The first end section 4 of the stent 2 is intended to be inserted into the mouth of a pulmonary vein. The tube 3 projects with its second end section 9 and the second end opening 11 beyond the second end opening 7 of the stent 2. The stent 2 here has two opposite (see Fig. 2 ) wire- or band-shaped stabilizing elements 12, which also protrude beyond the second end opening 7 of the stent 2 and support the tube 3 from the inside. Here, the wire- or band-shaped stabilizing elements 12 extend essentially to the second end opening 11 of the tube 3. The wire- or band-shaped stabilizing elements 12 ensure that the second end opening 11 of the flexible tube 3 remains open in the neutral state and does not collapse.

[0037] Figure 2shows simplified spatial views of the Figure 1 illustrated embodiments of the valve prosthesis 1 according to the invention. In Figure 2A is the Fig. 1A illustrated embodiment is reproduced in Figure 2B which in Fig. 1B The embodiment shown here shows the arrangement of the stabilizing elements 12 more clearly. Arrows indicate the direction in which the hose walls move when the hose 3 collapses under corresponding pressure conditions.

[0038] The two in the Figures 1 and 2The illustrated embodiments of the valve prosthesis 1 according to the invention differ only in that the first end section 4 of the stent 2 is either covered by the tube 3 (A) or kept free (B). Compared to the embodiment covered by the tube here, the embodiment with the first end section 4 kept free leads to a smaller reduction in the cross-section of the pulmonary vein 31 when the stent 2 is inserted into the pulmonary vein 31 with only the end section 4 kept free by the tube 3.

[0039] Figure 3 shows schematic views of various branched, Y-shaped embodiments of the valve prosthesis 1 according to the invention. Figure 3A In the embodiment shown, both the stent 2 and the tube 3 are branched in a Y-shape, while in the Figure 3B and Figure 3C In the embodiments shown, only the tube 3 is branched in a Y-shape. The stent 3 of the Figure 3AThe Y-shaped branched embodiment of the valve prosthesis 1 according to the invention shown is divided into first, second and third legs 13, 14 and 15. Accordingly, the tube 3 applied to the stent 3 also has first, second and third legs 16, 17 and 18. The third leg 15 of the stent 2 has a third end section 19 of the stent 2 with a third end opening 20. Accordingly, the tube also has a third end section 21 with an end opening 22. The tube 3 is not provided over the entire stent 2 here, but leaves the first end section 4 on the first leg 13 and the third end section 19 on the third leg 15 of the stent 2 free. These end sections 4, 19 are intended for anchoring in adjacent pulmonary veins 31.The tube 3 projects with its second end section 9 lying on the second tube leg 17 and its second end opening 11 beyond the second end opening 7 of the stent 3, and is supported in its free area from the inside by opposing wire- or band-shaped stabilizing elements 12 which are firmly connected to the stent 3.

[0040] In the Figures 3B and 3C The illustrated embodiments of the valve prosthesis 1 according to the invention are also Y-shaped. However, here only the tube 3 is branched in a Y-shape. In the end sections 8, 21 of the legs 16, 18 of the tube 3 are hollow cylindrical stents 2, which are not completely covered by the tube 3 here, but are exposed with their end sections 4, 19. Stabilizing elements 12 are also provided in these embodiments to support the tube from the inside and prevent it from collapsing in the neutral state. Figure 3CIn the embodiment shown, the cross section of the second tube leg 17 is wider than the tube cross section in the region of the tube legs 16, 18 in order to avoid flow limitation of the blood flow from two pulmonary veins 31 combined in the tube 3 during use.

[0041] In Figure 4 An installation situation is shown in a highly schematic manner. Shown is the left atrium 30, into which the four pulmonary veins 31 (upper and lower left and upper and lower right pulmonary veins) flow. The mitral valve region, as the transition to the left ventricle (not shown here), is only indicated by an opening 32. Shown are four embodiments of the valve prosthesis 1 according to the invention, implanted in the opening area of ​​the pulmonary veins 31, according to the Figures 1A and 2A. For the sake of clarity, not all reference numerals are repeated here. The stents 2 are completely covered by the tube 3 and their second end openings 7 are essentially aligned with the inner wall of the atrium 30. The second tube end sections 9 projecting beyond the end openings 7 extend into the atrium 30 and are supported by stabilizing elements 12 such that their end openings 11 are open in the neutral state. The inflow of blood from the pulmonary veins 31 into the atrium 30 is not impeded by the valve prostheses 1 according to the invention. However, if blood flows back from the ventricle into the atrium 30 due to mitral valve insufficiency, the tube end sections 9 collapse, closing the end openings 11, thereby preventing backflow of blood into the pulmonary veins 31.

[0042] The Figures 5 and 6show lateral views and cross sections through two further embodiments of the valve prosthesis 1 according to the invention. Figure 5 In the embodiment shown, the cross section of the tube 3 widens conically towards its second end opening 11. The second end opening 11 is thus wider than the first end opening 10, which prevents any retraction of the tube 3 into the stent 2, for example in negative pressure situations. Figure 6 In the embodiment shown, an annular reinforcing element 23 is provided for this purpose, which is arranged on the outside of the tube 3 and causes a stiffening and circumferential expansion in the second end section 9 of the tube 3, which also prevents the tube 3 from being pulled back into the stent 2.

[0043] The Figures 7 and 8 show two embodiments of a valve prosthesis 60 according to the invention, which are particularly well suited for use in the vena cavae 41, 42. Figure 7 shows the embodiments in a lateral, Figure 8 in a spatial view. The Figures 7A and 8A The embodiment shown differs from that shown in the Figures 7B and 8B illustrated embodiment in that the first end section 4 of the stent 2 is covered by the tube 3, while in the embodiment shown in the Figures 7B and 8B shown embodiment is kept free in each case.

[0044] The Figures 7 and 8 The illustrated embodiments of a valve prosthesis 60 according to the invention each consist of two valve prostheses 1, as shown in the Figures 1 and 2are shown, which are arranged with the second end openings 11 of their tubes 3 facing each other. The two valve prostheses 1 are spaced apart from each other so that a free space remains between the end openings 11 of their tubes 3. The free space is bridged by two wire- or band-shaped stabilizing elements 12, which are connected to each other or formed integrally with each other. In this way, two valve prostheses 1 according to the invention are combined to form a valve prosthesis 60, which can be implanted with the respective first end sections 4 of its stents 2 into the superior and inferior vena cava 41, 42.

[0045] Figure 9 shows the Figure 7B and Figure 8Billustrated embodiment of the valve prosthesis 60 according to the invention in the implanted state. Shown is a schematic cross-section through a human heart with the left atrium 30, the left ventricle 34 and the mitral valve 33 located therebetween, as well as the right atrium 40, the right ventricle 44 and the tricuspid valve 43 located therebetween. Pulmonary veins 31 open into the left atrium 30, the superior vena cava 41 and the inferior vena cava open into the right atrium 40. The valve prosthesis 60 according to the invention is implanted with the first end section 4 of the first stent 2 into the superior vena cava 41 and with the opposite first end section 4 of the second stent 2 into the inferior vena cava 42. For extravasal fastening of the valve prosthesis 60 according to the invention, a wire-shaped fastening element (61) is provided here, which is carried out, for example, via an implantation vein (e.g., subclavian vein) and, for example,can be fixed extravascularly with surgical suture material.

[0046] The second end openings 11 of the valve prosthesis 60 protrude freely into the right atrium 40, but are stabilized by the wire- or band-shaped stabilizing elements 12. Due to the valve design, in which the valve prosthesis 60 is open in the neutral state, no resistance needs to be overcome during physiological flow from the vena cavae 41, 42 toward the right atrium 40. The flow resistance is almost negligible in the valve prosthesis 60 described here, which can be advantageously used in cases of tricuspid valve insufficiency. In the case of unphysiological flow from the right atrium 40 toward the vena cavae 41, 42, negative pressure causes the valve prostheses 1 to collapse, thus resulting in proper valve closure. Backflow into the vena cavae 41, 42 and subsequent blood backflow into the liver and kidneys is thus prevented.The valve prosthesis 60 according to the invention can be used completely independently of the pathology and anatomical conditions of the tricuspid valve 43.

[0047] Figure 10 shows a sectional view of an embodiment of a valve prosthesis 1 according to the invention, as shown in Figure 1A is shown, in the closed state, ie, during valve closure. Opposing portions of the tube 3 extending beyond the second end opening 7 of the stent 2 lie closely adjacent to one another over the coaptation length L, so that a competent closure of the valve prosthesis 1 occurs. Example

[0048] The functionality of the valve prosthesis 1 according to the invention was confirmed using a model apparatus. For this purpose, an acrylic glass container with two openings was manufactured. An embodiment of the valve prosthesis 1 according to the invention was inserted into one of the openings. Figure 1A , 2A, mounted in such a way that the tube end section 9 protruded freely into the interior of the container. A tube to simulate a pulmonary vein was mounted on the first end section of the stent. A tube was led into the interior of the container through the second opening, through which colored fluid could be fed from an external container into the interior of the container to simulate mitral valve insufficiency. This also leads to an increase in pressure in the Plexiglas container. This causes the valve prostheses according to the invention to collapse. The valve prosthesis 1 according to the invention reliably prevented a backflow of fluid into the tube connected to the valve prosthesis 1 by collapsing the tube section protruding into the container.

[0049] In addition, a valve prosthesis 1, as used in the Figures 1A and 2Ashown, after induction of severe mitral valve insufficiency, they were implanted in the left atrial pulmonary veins of pig hearts and their functionality was examined by echocardiography and contrast angiography.

[0050] Figure 11 shows an echocardiogram of a pig heart with a left atrial valve prosthesis (LAC). Figure A shows the inventive valve prosthesis 1 (LAC) in the open state, Figure B in the closing state, and Figure C in the fully closed state. Measurement of the flow velocities (not shown) in the valve prosthesis 1 (LAC) and in the left atrium (LA) revealed, as expected, a unidirectional flow curve for the valve prosthesis 1 and a pendulum flow in the left atrium.

Claims

1. An implantable valve prosthesis (1), in particular for preventing blood reflux from a cardiac atrium into a vein opening into the atrium, comprising - a generally tubular stent (2) which may be branched or unbranched and which comprises at least a first end section (4) with a first end opening (6) and a second end section (5) with a second end opening (7), and - a flexible tube (3) which may be branched or unbranched and which has at least a first end section (8) with a first end opening (10) and a second end section (9) with a second end opening (11) which can be closed by collapsing the tube (3) and which is disposed at least in a sub-region of the second end section (9) of the stent (2) on the outer peripheral surface thereof in a manner such that the second end section (9) of the tube (3) with its second end opening (11) protrudes beyond the second end opening (7) of the stent (2), wherein the second end opening (11) of the tube (3) is open in the unpressurized state, characterized in that the tube (3) widens in cross section towards its second end opening (11) and / or the tube (3) is provided in its second end section (9) with an annular reinforcing element (23) fastened to the outside of the tube, the internal cross section of the annular reinforcing element (23) having an internal cross section corresponding to at least the internal cross section of the second end opening (7) of the stent (2).

2. The implantable valve prosthesis (1) as claimed in claim 1, further comprising - at least one wire- or ligature-shaped stabilization element (12) fastened to the stent (2) or integrally formed with the stent (2), wherein the stabilization element (12) protrudes beyond the second end opening (7) of the stent (2) and supports the portion of the tube (3) which protrudes beyond the second end opening (7) of the stent (2) from inside in a manner such that the second end opening (11) of the tube (3) is open in the unpressurized state and cannot gain ingress into the second end opening (7) of the stent (2) when pressure is applied.

3. The implantable valve prosthesis (1) as claimed in claim 2, wherein at least two wire- or ligature-shaped stabilization elements (12) which are opposite each other and which support the tube (3) from inside are present.

4. The implantable valve prosthesis (1) as claimed in one of claims 1 to 3, wherein the stent (2) and the tube (3) are unbranched and generally configured as a hollow cylinder.

5. The implantable valve prosthesis (1) as claimed in one of the preceding claims, wherein the tube (3) consists of body tissue, preferably of human or animal body tissue.

6. The implantable valve prosthesis (1) as claimed in one of the preceding claims, wherein the stent (2) consists of biocompatible metal or plastic.

7. The implantable valve prosthesis (1) as claimed in one of the preceding claims, wherein the stent (2) is covered by the tube (3) in the region of its entire outer peripheral surface.

8. The implantable valve prosthesis (1) as claimed in one of the preceding claims, wherein the tube (3) widens in cross section towards its second end opening (11) and wherein the second end section (9) of the tube (3) has an annular reinforcing element (23) fastened to the outside of the tube, the internal cross section of which element (23) being larger than the internal cross section of the second end opening (7) of the stent (2).

9. The implantable valve prosthesis (1) as claimed in one of the preceding claims, wherein the implantable valve prosthesis (1) is configured in a manner such that a coaptation length L of at least 1 cm, preferably at least 1.2 cm, 1.3 cm or 1.5 cm is produced.

10. The implantable valve prosthesis (1) as claimed in one of claims 1 to 3 or 5 to 9, wherein the stent (2) and / or the tube (3) are branched and generally Y-shaped in configuration.

11. The implantable valve prosthesis (1) as claimed in one of the preceding claims, wherein the implantable valve prosthesis (1) has a fastening element (61) for extravasal fastening of the implantable valve prosthesis (1).